Company intelligence / Profile preview

DeepBlue Medical

Ownership: Private
Development stage: Commercial

Overview

Anhui Deepblue is a leading Chinese IVD manufacturer with over a decade of experience producing rapid diagnostic tests across multiple disease areas. Their products include POCT kits for infectious and respiratory diseases as well as tumor markers and other clinical needs.

Therapeutic areas: PulmonologyOncologyInfectious DiseasesPsychiatryNephrologyWomen's Health
Modalities: Diagnostic reagentsPoint-of-care tests (POCT)
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on DeepBlue Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeepBlue Medical.

Explore the full profile